DekaBank Deutsche Girozentrale Acquires 341 Shares of GE HealthCare Technologies Inc. $GEHC

DekaBank Deutsche Girozentrale boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,371 shares of the company’s stock after acquiring an additional 341 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in GE HealthCare Technologies were worth $4,054,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. CMG Global Holdings LLC bought a new stake in GE HealthCare Technologies during the 2nd quarter worth approximately $1,329,000. Community Bank of Raymore raised its holdings in GE HealthCare Technologies by 11.8% during the second quarter. Community Bank of Raymore now owns 14,207 shares of the company’s stock worth $1,052,000 after buying an additional 1,500 shares during the last quarter. Burford Brothers Inc. raised its holdings in GE HealthCare Technologies by 5.7% during the second quarter. Burford Brothers Inc. now owns 8,516 shares of the company’s stock worth $631,000 after buying an additional 462 shares during the last quarter. Gladwyn Financial Advisors Inc. acquired a new position in GE HealthCare Technologies during the second quarter worth $34,000. Finally, Chevy Chase Trust Holdings LLC raised its holdings in shares of GE HealthCare Technologies by 0.8% in the second quarter. Chevy Chase Trust Holdings LLC now owns 243,192 shares of the company’s stock valued at $18,013,000 after purchasing an additional 1,948 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently weighed in on GEHC shares. Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. Barclays started coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. BTIG Research raised their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Finally, Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $93.00 to $83.00 in a research note on Tuesday, October 7th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $85.20.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $78.14 on Friday. The stock has a market cap of $35.68 billion, a P/E ratio of 16.01, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13. The firm’s fifty day simple moving average is $74.78 and its 200 day simple moving average is $72.53. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter in the previous year, the business posted $1.00 earnings per share. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s payout ratio is 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.